GREMF Stock UPDATES Gener8 Media (GREMF) 0.8200 08/30/2014 0

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gener8 Media (GREMF) 0.8200 $GREMF

Gener8 Announces its Second Quarter Results
ACCESSWIRE - Tue Aug 26, 8:32PM CDT
VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / August 26, 2014 - Gener8 Media Corp. (CSE: GNR) ("Gener8" or the "Company" is pleased to announce the release of its unaudited financial results for the second quarter ended June 30, 2014. All figures are in Canadian dollars.

Gener8 FFD Partnership Agreement Update
ACCESSWIRE - Tue Aug 05, 8:08AM CDT
VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / August 5, 2014 / Gener8 Media Corp. (CSE: GNR) ("Gener8" or the "Company" continues to work toward closing its previously announced partnership agreement with Tianjin Fu Feng Da Movie & Television Technology Investment and Development Co., Ltd. ("FFD" . The Company is pleased to announce that on Wednesday, July 30 FFD received the second of three certifications required from the Chinese government in order to complete the transaction.

Gener8 Signs 3D Conversion Contract for Hollywood Feature
ACCESSWIRE - Mon Jul 21, 6:09PM CDT
VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / July 21, 2014 / Gener8 Media Corp. (CNSX: GNR) ("Gener8" or the "Company" is pleased to announce the signing of a 3D conversion contract with a major Hollywood studio for a feature film to be released in 2015. The contract is for converting the entire movie. Due to contractual obligations, Gener8 is unable to provide specific details about the studio or the title of the movie.

Gener8 Announces Annual General Meeting Results and Corporate Update
ACCESSWIRE - Wed Jul 02, 11:37AM CDT
VANCOUVER, BC / ACCESSWIRE / July 2, 2014 / Gener8 Media Corp. (CSE: GNR) ("Gener8" or the "Company" is pleased to announce the results of the Company's annual and special general shareholder meeting (the "AGM" . The AGM was a success with over 98% approval on all resolutions presented at the meeting including: appointing KPMG LLP as Gener8's auditors, setting the number of Directors at four, with Rory Armes, Ken Scott, Neil Murdoch and Tim Bennison reappointed, approving advance notice provisions for the nomination of directors by shareholders to be added to Company's articles, and approving the Company's 10% rolling stock option plan.

Gener8 Signs Two New Cumul8 Clients
ACCESSWIRE - Tue Jun 17, 11:11AM CDT
VANCOUVER, BC / ACCESSWIRE / June 17, 2014 / Gener8 Media Corp. (CSE: GNR) ("Gener8" or the "Company" is pleased to announce the signing of two new Cumul8 contracts. The first contract adds to Cumul8's growing client base in the entertainment sector, where the technology got its start. The second contract opens up a new sector in the manufacturing industry. This contract, with a California-based OEM parts manufacturer to the aerospace industry, represents Cumul8's first foray outside of media and entertainment.

Bill Harrison, Cumul8 Chief Business Officer; to Present at MC2 MTConnect. Harrison, a Leading Expert in Leveraging Big Data for the Entertainment Industry, will Share Valuable ...
ACCESSWIRE - Tue Mar 25, 4:04PM CDT
VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / March 25, 2014 / Gener8 Media Corp. (CSE: GNR), a leader in 3D film conversion and data management software solutions for the entertainment industry, announced today that Bill Harrison, chief business officer for Cumul8, a division of Gener8, has been invited to speak at the [MC]2 MTConnect conference. Harrison will be co-presenting with Rebecca Taylor, senior vice president for the National Center for Manufacturing Sciences. As chief business officer for Gener8's Cumul8 data management and analytics division, Harrison has gained tremendous insight and first-hand experience in leveraging big data techniques and technologies to improve the efficiencies of the post-production process. In his presentation, Harrison will discuss Gener8's history in films and gaming, the company's big data insights and how manufacturers can leverage similar technologies and techniques to transform the manufacturing industry.

Gener8 Announces Signing of 3D Conversion Partnership Agreement
ACCESSWIRE - Tue Mar 18, 9:50PM CDT
VANCOUVER, BRITISH COLUMBIA, / ACCESSWIRE / March 18, 2014 / Gener8 Media Corp. (CSE: GNR) ("Gener8" or the "Company" is pleased to announce that it has signed an investment and partnership agreement with Tianjin Fu Feng Da Movie & Television Technology Investment and Development Co., Ltd. ("FFD" , pursuant to the letter of intent ("LOI" previously announced on November 4, 2013.

Gener8 Takes Majority Interest in Reelhouse
ACCESSWIRE - Tue Feb 25, 12:26PM CST
VANCOUVER, BRITISH COLUMBIA, February 25, 2014 - Gener8 Media Corp. (CSE: GNR) ("Gener8" or "Company" announced it has increased its interest in Reelhouse Media Ltd. ("Reelhouse" from 48% to 66%, taking a majority equity position in the disruptive film distribution platform that has attracted the attention of both the independent film community and major Hollywood studios such as Warner Brothers.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 170

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 211

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 268

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 227

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 234

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 84

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 186

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 193

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of the Sodium Bisulfite Market by 2034

Updated Category News Views 133

Understanding the Growth of the Sodium Bisulfite Market The sodium bisulfite market is experiencing significant momentum as it progresses towards a bright future, with expectations of reaching USD 1,180.7 million by 2034, up from USD 750.3 million in 2024. This growth is driven by an increasing awareness of environmental issues and its versatile applications in various...

Continue Reading
Photocure ASA Reports Impressive Q2 Growth and Outlook

Updated Category News Views 153

Photocure ASA Achieves Record Revenue in Q2 Photocure ASA has shared strong results for the second quarter of the year, showcasing remarkable growth in its Hexvix/Cysview product line. This quarter marked an unprecedented achievement with revenues reaching NOK 135.6 million, reflecting a significant increase compared to NOK 122.4 million from the same period last year....

Continue Reading
Ben & Jerry's Unveils New Flavor Inspired by Noah Kahan

Updated Category News Views 273

Ben & Jerry's Launches Exclusive Flavor with Noah Kahan Ben & Jerry's, the iconic ice cream brand that loves to explore creative flavors, has just introduced an exciting new flavor called Northern Latte-tude. This one-of-a-kind creation is the result of a collaboration with musician Noah Kahan, with the goal of not only delighting fans but also supporting an important...

Continue Reading
Cisco Analyst Coverage Initiation Highlights: Stocks to Watch

Updated Category News Views 141

Latest Analyst Ratings on Notable Stocks In a dynamic market environment, top analysts analyze and provide insights on various companies. Recently, several key analysts have shared significant ratings and price targets for notable stocks, including Cisco Systems, Inc. (NASDAQ: CSCO) and Shopify Inc. (NASDAQ: SHOP). Let's delve into what they have to say. Shopify Inc....

Continue Reading
Nike's Leadership Shakeup: A Bright Future Ahead for the Brand

Updated Category News Views 205

Nike's Steady Outlook Amid Leadership Changes BMO Capital Markets has recently reaffirmed its Outperform rating for Nike Inc. (NYSE:NKE), setting a price target at $92.00 per share. This positive outlook follows the recent appointment of Elliott Hill as President and CEO, a change many investors have eagerly awaited. Hill's return is seen as a hopeful sign for the...

Continue Reading